Atridia Pty Ltd.
Clinical trials sponsored by Atridia Pty Ltd., explained in plain language.
-
New obesity drug HRS-5817 enters human safety testing
Disease control OngoingThis early-phase trial tests the safety of a single dose of HRS-5817 in 40 obese adults aged 18-55. Participants receive either the drug or a placebo by injection. The study monitors side effects and how the drug moves through the body.
Phase: EARLY_PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug SHR-2173 put to the test in healthy volunteers
Knowledge-focused OngoingThis early-stage study is testing a single dose of a new drug called SHR-2173 in 18 healthy adults. The goal is to see how safe it is, how the body absorbs and breaks it down, and whether the immune system reacts to it. Participants will be randomly assigned to receive either the…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New psoriasis drug candidate SHR-1139 begins first human safety check
Knowledge-focused OngoingThis early-stage study is testing a single dose of an experimental drug called SHR-1139 in 24 healthy adults. The main goal is to see how safe the drug is and how the body processes it, not to treat any disease. Participants are healthy men and women aged 18 to 55. The results wi…
Phase: PHASE1 • Sponsor: Atridia Pty Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC